GlassScriptPhysician profile
Morgan Mcfarland
NPI 1275371114
$3,693.00
in general payments reported to CMS, 2019-2025
20 companies · $3,693 in 2025
The $3,693 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $3,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,494 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,493.75 |
| Education | $199.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $708.99 | 2025 | Tremfya |
| Incyte Corporation | $670.75 | 2025 | Opzelura, Opzelura |
| Regeneron Healthcare Solutions, INC. | $486.85 | 2025 | Dupixent, Libtayo |
| Ucb, INC. | $475.38 | 2025 | Bimzelx |
| Abbvie INC. | $378.26 | 2025 | |
| Genzyme Corporation | $290.28 | 2025 | |
| Janssen Scientific Affairs, LLC | $118.72 | 2025 | Tremfya |
| Lilly USA, LLC | $104.80 | 2025 | Ebglyss, Taltz |
| Sun Pharmaceutical Industries INC. | $82.47 | 2025 | |
| Organon LLC | $69.26 | 2025 | Hadlima |
| Novartis Pharmaceuticals Corporation | $68.96 | 2025 | |
| Leo Pharma INC. | $41.15 | 2025 | Anzupgo |
| Galderma Laboratories, L.P. | $38.20 | 2025 | |
| Pfizer INC. | $29.60 | 2025 | |
| Mallinckrodt Hospital Products INC. | $23.72 | 2025 | Acthar |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $22.81 | 2025 | |
| Botanix Sb INC | $22.13 | 2025 | Sofdra |
| E.R. Squibb & Sons, L.L.C. | $21.74 | 2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.53 | 2025 | Cabtreo |
| Verrica Pharmaceuticals INC. | $17.40 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Mcfarland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.